<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-16995" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biochemistry, 5 Hydroxyindoleacetic Acid</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lenchner</surname>
            <given-names>Jennifer R.</given-names>
          </name>
          <aff>LECOM - Seton Hill</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Santos</surname>
            <given-names>Cynthia</given-names>
          </name>
          <aff>Rutgers New Jersey Medical School</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jennifer Lenchner declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Cynthia Santos declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-16995.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>5-Hydroxy indoleacetic acid (5-HIAA) is the primary metabolite of serotonin. Serotonin is broken down into 5-hydroxy indoleacetic acid within the liver. 5-hydroxy indoleacetic acid is used as a proxy for serotonin measurement through a 24-hour urine test.<xref ref-type="bibr" rid="article-16995.r1">[1]</xref><xref ref-type="bibr" rid="article-16995.r2">[2]</xref>&#x000a0;5-hydroxy indoleacetic acid's primary use is in&#x000a0;diagnosing and monitoring carcinoid&#x000a0;tumors, a subset of serotonin secreting neuroendocrine tumors.&#x000a0;</p>
      </sec>
      <sec id="article-16995.s2" sec-type="Fundamentals">
        <title>Fundamentals</title>
        <p>5-hydroxy indoleacetic acid starts as tryptophan within cells. Tryptophan then converts to serotonin. After that, monoamine oxidase A (MAO-a) enzymatically deactivates serotonin by converting it to 5-hydroxy indoleacetic acid within the synaptic cleft. Serotonin generally gets metabolized by the liver before entering the general circulation and having more downstream effects. Serotonin may also be deactivated and taken out of circulation by the lungs.<xref ref-type="bibr" rid="article-16995.r3">[3]</xref><xref ref-type="bibr" rid="article-16995.r4">[4]</xref></p>
      </sec>
      <sec id="article-16995.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <list list-type="order">
          <list-item>
            <p>Strenuous exercise may raise 5-HIAA levels.<xref ref-type="bibr" rid="article-16995.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Certain foods and drugs affect 5-HIAA levels if eaten within 48 hours of the test. Foods that may increase urine 5-HIAA levels include pineapple, banana, kiwi fruit, tomato, or walnuts.<xref ref-type="bibr" rid="article-16995.r6">[6]</xref><xref ref-type="bibr" rid="article-16995.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Medicines that lower urine 5-HIAA levels&#x000a0;include risperidone&#x000a0;and acetaminophen.<xref ref-type="bibr" rid="article-16995.r8">[8]</xref> The mechanism by which acetaminophen decreases urinary 5-HIAA, and conversely increases brain serotonin levels, is by inhibiting hepatic tryptophan 2,3-dioxygenase.<xref ref-type="bibr" rid="article-16995.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Medicines that lower CSF 5-HIAA levels are: desipramine and zimeldine.<xref ref-type="bibr" rid="article-16995.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Dialysis has been shown to decrease CSF levels of 5-HIAA.<xref ref-type="bibr" rid="article-16995.r11">[11]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-16995.s4" sec-type="Function">
        <title>Function</title>
        <p>5-hydroxy indoleacetic acid use as a proxy to measure serotonin levels is important because of serotonin&#x02019;s systemic effects and prognostic capacity. Serotonin is mainly secreted by enterochromaffin cells in the gastrointestinal system and, to a lesser extent, by neurons within the nervous system.<xref ref-type="bibr" rid="article-16995.r12">[12]</xref><xref ref-type="bibr" rid="article-16995.r13">[13]</xref><xref ref-type="bibr" rid="article-16995.r14">[14]</xref>&#x000a0;Serotonin secretion causes a cascade of effects as it is picked up by a variety of cells that store the hormone for later use. For example, platelets will store serotonin until the platelet is activated and releases the serotonin to induce local vasoconstriction and help stimulate an immune response.<xref ref-type="bibr" rid="article-16995.r15">[15]</xref><xref ref-type="bibr" rid="article-16995.r16">[16]</xref>&#x000a0;In carcinoid tumors, excessive serotonin is produced, thus raising the levels of urinary 5-hydroxy indoleacetic acid. 5-hydroxy indoleacetic&#x000a0;acid is primarily&#x000a0;a biomarker for midgut carcinoid tumors but may also be useful in characterizing a variety of diseases and disorders.&#x000a0;Diseases or disorders in which urinary 5-hydroxy indoleacetic acid increases include intestinal neuroendocrine tumors, celiac disease, cystic fibrosis, and autism spectrum disorder. Diseases or disorders that display lower than normal urinary 5-hydroxy indoleacetic acid levels include obsessive-compulsive&#x000a0;disorder, aromatic L-amino acid decarboxylation deficiency, sepiapterin reductase deficiency, and multiple sclerosis.</p>
      </sec>
      <sec id="article-16995.s5" sec-type="Testing">
        <title>Testing</title>
        <p>Measurement of 5-hydroxy indoleacetic acid levels is&#x000a0;through a 24-hour urine sample; this requires the patient to collect all their urine produced over 24 hours. To prepare for an accurate urine sample of 5-hydroxy indoleacetic acid levels, ask your provider about food or medication restrictions needed before urine collection as well as any specific testing instructions. Testing instructions may include time collection strategies. For example, voiding one&#x02019;s bladder in the morning after you wake up and mark that time, from then on, collecting urine until you reach 24 hours from that initial time mark.<xref ref-type="bibr" rid="article-16995.r17">[17]</xref></p>
        <p>The normal range for 5-hydroxy indoleacetic acid measured in urine is 3&#x000a0;to 15 mg/24 hours. The upper limit of 5-hydroxy indoleacetic acid measurements may vary depending on the laboratory used in the analysis.<xref ref-type="bibr" rid="article-16995.r17">[17]</xref></p>
        <p>Urine 5-hydroxy indoleacetic acid testing is useful for primary midgut carcinoid tumors, including jejunoileal, ascending colon, and appendiceal. In patients with primary midgut carcinoid tumors, 5-hydroxy indoleacetic acid levels may decrease during treatment, which may reflect the patient&#x02019;s response to treatment. Increased or increasing 5-hydroxy indoleacetic acid levels indicate a non-response to treatment. Carcinoid tumors of the foregut and hindgut rarely secrete serotonin, so 5-hydroxy indoleacetic acid urine testing is not as useful for their detection. Foregut and hindgut carcinoid tumors cannot convert 5-HTP to serotonin because of DOPA decarboxylase deficiency.<xref ref-type="bibr" rid="article-16995.r7">[7]</xref></p>
      </sec>
      <sec id="article-16995.s6" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>5-hydroxy indoleacetic acid is essential in diagnosing and monitoring carcinoid&#x000a0;tumors. Clinicians need to distinguish carcinoid tumors from carcinoid syndrome. Carcinoid tumors are a form of&#x000a0;neuroendocrine tumor within the gastrointestinal or pulmonary system. Midgut carcinoid tumors secrete serotonin, whereas foregut and midgut carcinoid tumors do not. Carcinoid syndrome&#x000a0;is a&#x000a0;paraneoplastic syndrome secondary to carcinoid tumors with symptoms&#x000a0;including but not limited to&#x000a0;cutaneous flushing, diarrhea,&#x000a0;nausea, vomiting, hepatomegaly, cardiac murmurs, coughing, shortness of breath, and wheezing. Furthermore, 5-hydroxy indoleacetic acid may be an essential biomarker for inborn errors of metabolism, diseases of malabsorption, as well as psychiatric conditions.</p>
      </sec>
      <sec id="article-16995.s7" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <list list-type="order">
          <list-item>
            <p>Elevated levels of 5-hydroxy indoleacetic acid are present in carcinoid tumors, carcinoid syndrome.&#x000a0;For carcinoid tumors, 5-hydroxy indoleacetic acid urine test has a specificity of 100% and sensitivity of 73%.<xref ref-type="bibr" rid="article-16995.r14">[14]</xref><xref ref-type="bibr" rid="article-16995.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Urinary 5-hydroxy indoleacetic acid levels over five&#x000a0;times the upper limit of normal were found to be a weak prognostic indicator for patients with small intestine neuroendocrine tumors.<xref ref-type="bibr" rid="article-16995.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p>Elevated levels of 5-hydroxy indoleacetic acid occur in patients of autism spectrum disorder.<xref ref-type="bibr" rid="article-16995.r20">[20]</xref><xref ref-type="bibr" rid="article-16995.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Lower levels have correlated with aggressive or violent behavior, depression, and obsessive-compulsive disorder.<xref ref-type="bibr" rid="article-16995.r21">[21]</xref></p>
          </list-item>
          <list-item>
            <p>Diseases of malabsorption may present with increased urinary&#x000a0;5-hydroxy indoleacetic acid.<xref ref-type="bibr" rid="article-16995.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Increased 5-hydroxy indoleacetic acid levels correlate with type 2 diabetes patients with microalbuminuria that developed renal insufficiency and impaired blood flow to their lower extremities.<xref ref-type="bibr" rid="article-16995.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>A shorter 5-hydroxy indoleacetic acid DT in patients with small intestine or unknown primary&#x000a0;neuroendocrine tumors&#x000a0;correlated with a higher risk of disease progression.<xref ref-type="bibr" rid="article-16995.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Altered levels of 5-hydroxy indoleacetic acid are present in IBS patients vs. controls.<xref ref-type="bibr" rid="article-16995.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Levels of 5-hydroxy indoleacetic acid undergo alteration in various inborn errors of metabolism. Decreased levels of 5-hydroxy indoleacetic acid are present in aromatic L-amino acid decarboxylation deficiency, sepiapterin reductase deficiency.<xref ref-type="bibr" rid="article-16995.r24">[24]</xref><xref ref-type="bibr" rid="article-16995.r25">[25]</xref>&#x000a0;Increased levels of 5-hydroxy indoleacetic acid are present in patients with celiac disease.<xref ref-type="bibr" rid="article-16995.r26">[26]</xref>&#x000a0;Additionally, celiac disease patients were found to have increased numbers of enterochromaffin cells and platelet 5-HT stores. Treatment with a gluten-free diet was shown to help&#x000a0;normalize urinary 5-hydroxy indoleacetic acid levels in celiac patients.<xref ref-type="bibr" rid="article-16995.r27">[27]</xref><xref ref-type="bibr" rid="article-16995.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Cystic fibrosis patients were found to have higher blood serotonin levels&#x000a0;and normal 5-HIAA urinary excretion levels in one study, but in other studies, CSF and urinary 5-hydroxy-indoleacetic acid levels were found to have increased in cystic fibrosis patients.<xref ref-type="bibr" rid="article-16995.r29">[29]</xref><xref ref-type="bibr" rid="article-16995.r30">[30]</xref><xref ref-type="bibr" rid="article-16995.r31">[31]</xref></p>
          </list-item>
          <list-item>
            <p>5-hydroxy indoleacetic acid levels were found to be positively correlated with FEV1/FVC and negatively correlated with bronchial inflammatory marker, eNO.<xref ref-type="bibr" rid="article-16995.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Urinary 5-hydroxy indoleacetic acid levels were found to be lower in patients with multiple sclerosis. Furthermore, levels of 5-hydroxy indoleacetic acid were found to relate to the severity of disease symptoms in relapsing-remitting multiple sclerosis patients.<xref ref-type="bibr" rid="article-16995.r32">[32]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-16995.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=16995&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=16995">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/16995/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=16995">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-16995.s9">
        <title>References</title>
        <ref id="article-16995.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deacon</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>The measurement of 5-hydroxyindoleacetic acid in urine.</article-title>
            <source>Ann Clin Biochem</source>
            <year>1994</year>
            <month>May</month>
            <volume>31 ( Pt 3)</volume>
            <fpage>215</fpage>
            <page-range>215-32</page-range>
            <pub-id pub-id-type="pmid">7520678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adaway</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Dobson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cuthbertson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Monaghan</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Trainer</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Valle</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Keevil</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement.</article-title>
            <source>Ann Clin Biochem</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>53</volume>
            <issue>Pt 5</issue>
            <fpage>554</fpage>
            <page-range>554-60</page-range>
            <pub-id pub-id-type="pmid">26438520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hart</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Block</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Lung serotonin metabolism.</article-title>
            <source>Clin Chest Med</source>
            <year>1989</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-70</page-range>
            <pub-id pub-id-type="pmid">2650964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hilaire</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Voituron</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Menuet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ichiyama</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Subramanian</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Dutschmann</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The role of serotonin in respiratory function and dysfunction.</article-title>
            <source>Respir Physiol Neurobiol</source>
            <year>2010</year>
            <month>Nov</month>
            <day>30</day>
            <volume>174</volume>
            <issue>1-2</issue>
            <fpage>76</fpage>
            <page-range>76-88</page-range>
            <pub-id pub-id-type="pmid">20801236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Melancon</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Lorrain</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dionne</surname>
                <given-names>IJ</given-names>
              </name>
            </person-group>
            <article-title>Exercise and sleep in aging: emphasis on serotonin.</article-title>
            <source>Pathol Biol (Paris)</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>62</volume>
            <issue>5</issue>
            <fpage>276</fpage>
            <page-range>276-83</page-range>
            <pub-id pub-id-type="pmid">25104243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tohmola</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Johansson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sane</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Renkonen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>H&#x000e4;m&#x000e4;l&#x000e4;inen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Itkonen</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Transient elevation of serum 5-HIAA by dietary serotonin and distribution of 5-HIAA in serum protein fractions.</article-title>
            <source>Ann Clin Biochem</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>Pt 4</issue>
            <fpage>428</fpage>
            <page-range>428-33</page-range>
            <pub-id pub-id-type="pmid">25249663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Urinary serotonin in the diagnosis of carcinoid tumors.</article-title>
            <source>Clin Chem</source>
            <year>1986</year>
            <month>May</month>
            <volume>32</volume>
            <issue>5</issue>
            <fpage>840</fpage>
            <page-range>840-4</page-range>
            <pub-id pub-id-type="pmid">2421946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aymard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Viala</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Clement</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Jacquot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vacheron</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Gauillard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Caroli</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone. Plasma and red blood cell concentrations of risperidone and its 9-hydroxymetabolite and their relationship to whole blood serotonin and tryptophan, plasma homovanillic acid, 5-hydroxyindoleacetic acid, dihydroxyphenylethyleneglycol and clinical evaluations.</article-title>
            <source>Prog Neuropsychopharmacol Biol Psychiatry</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>975</fpage>
            <page-range>975-88</page-range>
            <pub-id pub-id-type="pmid">12369274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anoopkumar-Dukie</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Acetaminophen inhibits liver trytophan-2,3-dioxygenase activity with a concomitant rise in brain serotonin levels and a reduction in urinary 5-hydroxyindole acetic acid.</article-title>
            <source>Life Sci</source>
            <year>2000</year>
            <month>Jun</month>
            <day>08</day>
            <volume>67</volume>
            <issue>3</issue>
            <fpage>235</fpage>
            <page-range>235-40</page-range>
            <pub-id pub-id-type="pmid">10983867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Potter</surname>
                <given-names>WZ</given-names>
              </name>
              <name>
                <surname>Scheinin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Golden</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Rudorfer</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Cowdry</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Calil</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Linnoila</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.</article-title>
            <source>Arch Gen Psychiatry</source>
            <year>1985</year>
            <month>Dec</month>
            <volume>42</volume>
            <issue>12</issue>
            <fpage>1171</fpage>
            <page-range>1171-7</page-range>
            <pub-id pub-id-type="pmid">2416297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sullivan</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Murnaghan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Callaghan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kantamaneni</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Curzon</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1980</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>8</issue>
            <fpage>739</fpage>
            <page-range>739-43</page-range>
            <pub-id pub-id-type="pmid">6159456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jayamohananan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Manoj Kumar</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>T P</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>5-HIAA as a Potential Biological Marker for Neurological and Psychiatric Disorders.</article-title>
            <source>Adv Pharm Bull</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>374</fpage>
            <page-range>374-381</page-range>
            <pub-id pub-id-type="pmid">31592064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tirosh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nilubol</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kebebew</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors.</article-title>
            <source>Endocr Pract</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>710</fpage>
            <page-range>710-717</page-range>
            <pub-id pub-id-type="pmid">30084688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Carcinoid-syndrome: recent advances, current status and controversies.</article-title>
            <source>Curr Opin Endocrinol Diabetes Obes</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-35</page-range>
            <pub-id pub-id-type="pmid">29120923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chojnacki</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>B&#x00142;o&#x00144;ska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaczka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chojnacki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>St&#x00119;pie&#x00144;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>G&#x00105;siorowska</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of serotonin and dopamine secretion and metabolism in patients with irritable bowel syndrome.</article-title>
            <source>Pol Arch Intern Med</source>
            <year>2018</year>
            <month>Nov</month>
            <day>30</day>
            <volume>128</volume>
            <issue>11</issue>
            <fpage>711</fpage>
            <page-range>711-713</page-range>
            <pub-id pub-id-type="pmid">30398468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papamichael</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Katsardis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Erbas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Itsiopoulos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tsoukalas</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Urinary organic acids as biomarkers in the assessment of pulmonary function in children with asthma.</article-title>
            <source>Nutr Res</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>61</volume>
            <fpage>31</fpage>
            <page-range>31-40</page-range>
            <pub-id pub-id-type="pmid">30683437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maroun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kocha</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kvols</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bjarnason</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Germond</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hanna</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Poitras</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rayson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sideris</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Siu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group.</article-title>
            <source>Curr Oncol</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>67</fpage>
            <page-range>67-76</page-range>
            <pub-id pub-id-type="pmid">17576444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>O'Dorisio</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors.</article-title>
            <source>Am J Med</source>
            <year>1986</year>
            <month>Dec</month>
            <day>22</day>
            <volume>81</volume>
            <issue>6B</issue>
            <fpage>41</fpage>
            <page-range>41-8</page-range>
            <pub-id pub-id-type="pmid">2432780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laskaratos</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Diamantopoulos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walton</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Khalifa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>El-Khouly</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Koffas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Demetriou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Caplin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toumpanakis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mandair</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia.</article-title>
            <source>Neuroendocrinology</source>
            <year>2018</year>
            <volume>106</volume>
            <issue>4</issue>
            <fpage>366</fpage>
            <page-range>366-380</page-range>
            <pub-id pub-id-type="pmid">29320779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruggeri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sarkans</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Schumann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Persico</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Biomarkers in autism spectrum disorder: the old and the new.</article-title>
            <source>Psychopharmacology (Berl)</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>231</volume>
            <issue>6</issue>
            <fpage>1201</fpage>
            <page-range>1201-16</page-range>
            <pub-id pub-id-type="pmid">24096533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spreux-Varoquaux</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Berlin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Batista</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Despierre</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Gilton</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cremniter</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression.</article-title>
            <source>Life Sci</source>
            <year>2001</year>
            <month>Jun</month>
            <day>29</day>
            <volume>69</volume>
            <issue>6</issue>
            <fpage>647</fpage>
            <page-range>647-57</page-range>
            <pub-id pub-id-type="pmid">11476186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ballo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dattolo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mangialavori</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fusco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Consalvo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chiodi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pizzarelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zuppiroli</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute inflammatory bowel disease complicating chronic alcoholism and mimicking carcinoid syndrome.</article-title>
            <source>Case Rep Gastroenterol</source>
            <year>2012</year>
            <month>May</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>545</fpage>
            <page-range>545-9</page-range>
            <pub-id pub-id-type="pmid">22949895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saito</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tajima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takami</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Horikawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Increased plasma serotonin metabolite 5-hydroxyindole acetic acid concentrations are associated with impaired systolic and late diastolic forward flows during cardiac cycle and elevated resistive index at popliteal artery and renal insufficiency in type 2 diabetic patients with microalbuminuria.</article-title>
            <source>Endocr J</source>
            <year>2016</year>
            <volume>63</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-76</page-range>
            <pub-id pub-id-type="pmid">26567921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manegold</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Degen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ikonomidou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Knust</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laass</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Pritsch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wilichowski</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>H&#x000f6;rster</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up.</article-title>
            <source>J Inherit Metab Dis</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>371</fpage>
            <page-range>371-80</page-range>
            <pub-id pub-id-type="pmid">19172410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abeling</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Duran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bakker</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Stroomer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Th&#x000f6;ny</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blau</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Booij</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Poll-The</surname>
                <given-names>BT</given-names>
              </name>
            </person-group>
            <article-title>Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia.</article-title>
            <source>Mol Genet Metab</source>
            <year>2006</year>
            <season>Sep-Oct</season>
            <volume>89</volume>
            <issue>1-2</issue>
            <fpage>116</fpage>
            <page-range>116-20</page-range>
            <pub-id pub-id-type="pmid">16650784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Challacombe</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Storrie</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Increased excretion of 5-hydroxyindoleacetic acid in urine of children with untreated coeliac disease.</article-title>
            <source>Arch Dis Child</source>
            <year>1972</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>253</issue>
            <fpage>442</fpage>
            <page-range>442-5</page-range>
            <pub-id pub-id-type="pmid">5034674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coleman</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Foley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dunlop</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Wheatcroft</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blackshaw</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Perkins</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marsden</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Spiller</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>4</volume>
            <issue>7</issue>
            <fpage>874</fpage>
            <page-range>874-81</page-range>
            <pub-id pub-id-type="pmid">16797248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hallert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sedvall</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Improvement in central monoamine metabolism in adult coeliac patients starting a gluten-free diet.</article-title>
            <source>Psychol Med</source>
            <year>1983</year>
            <month>May</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-71</page-range>
            <pub-id pub-id-type="pmid">6192458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Partington</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Ferguson</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Serotonin metabolism in cystic fibrosis.</article-title>
            <source>Arch Dis Child</source>
            <year>1977</year>
            <month>May</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>386</fpage>
            <page-range>386-90</page-range>
            <pub-id pub-id-type="pmid">869568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kollberg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;ni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>T&#x000fc;rler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>K&#x000e4;ser</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bard&#x000f3;n</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ceder</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Stanghelle</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Maehlum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Skyberg</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Dopamine and catecholamines in cystic fibrosis in response to a marathon race.</article-title>
            <source>Int J Sports Med</source>
            <year>1988</year>
            <month>Feb</month>
            <volume>9 Suppl 1</volume>
            <fpage>56</fpage>
            <page-range>56-9</page-range>
            <pub-id pub-id-type="pmid">3360546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000f6;ni</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>T&#x000fc;rler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>K&#x000e4;ser</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kraemer</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Plasma and urinary catecholamines in patients with cystic fibrosis.</article-title>
            <source>Pediatr Res</source>
            <year>1985</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-52</page-range>
            <pub-id pub-id-type="pmid">3969312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-16995.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markianos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koutsis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Evangelopoulos</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Mandellos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Karahalios</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sfagos</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.</article-title>
            <source>J Neurochem</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>108</volume>
            <issue>1</issue>
            <fpage>158</fpage>
            <page-range>158-64</page-range>
            <pub-id pub-id-type="pmid">19014375</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
